Latest filing published 03 Jan 2011 for DRUGMAX INC.
No signal scores available.
Kellogg Capital Markets, LLC is a declared insider at 2 companies; the most frequent names are Drugmax Inc and Remec Inc. The record holds 2 filings, for trades running from 7 January 2010 to 29 December 2010.
Sales make up the whole of the open-market record (1 sale, €1.9M).
The newest entry dates from 3 January 2011: a transaction, in Drugmax Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations